FIELD: biotechnology.
SUBSTANCE: invention discloses T-cells for treating cancer, containing a chimeric antigen receptor (CAR), which specifically binds to a B-cell maturation antigen (BCMA), as well as a composition for treating cancer, comprising a T-cell and a pharmaceutically acceptable carrier.
EFFECT: group of inventions is used for treating oncological diseases.
17 cl, 14 tbl, 30 dwg, 7 ex
Title | Year | Author | Number |
---|---|---|---|
INDUCED CASPASES AND METHODS FOR THEIR USE | 2017 |
|
RU2757058C2 |
METHOD OF PRODUCING PROTEIN | 2011 |
|
RU2598255C2 |
EXPRESSION OF NEW CELL MARKS | 2018 |
|
RU2796334C2 |
TRANSPOSASE POLYPEPTIDES AND USE THEREOF | 2016 |
|
RU2735700C2 |
METHOD OF PRODUCING PROTEIN | 2010 |
|
RU2563514C2 |
IMPROVED TRANSGENE EXPRESSION AND PROCESSING | 2014 |
|
RU2808756C1 |
CHIMERIC ANTIGEN RECEPTORS AND THEIR PRODUCTION METHODS | 2015 |
|
RU2753965C2 |
METHODS FOR PRODUCTION OF COMPOSITIONS OF GENETICALLY ENGINEERED CELLS AND RELATED COMPOSITIONS | 2018 |
|
RU2790444C2 |
REAGENTS FOR REPRODUCTION OF CELLS EXPRESSING RECOMBINANT RECEPTORS | 2018 |
|
RU2783956C2 |
ARTIFICIAL NUCLEIC ACID MOLECULES COMPRISING 5'TOP UTR | 2013 |
|
RU2660565C2 |
Authors
Dates
2024-06-06—Published
2018-12-20—Filed